Patients confident to use injectable PCSK9-inhibitor via self-injection
Dr. Bertrand Cariou (Université de Nantes, Nantes, France)
Recorded at ISA2015, Amsterdam, The Netherlands on May 24-26, 2015
ISA2015 | Clinical Breakthroughs Dr. Bertrand Cariou presents data of a study that investigated the willingness of patients and physicians to use self-injections (either by prefilled pen or a prefilled syringe) to administer the PCSK9-antibody alirocumab.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.